1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 23 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2017Leptin signals via TGFB1 to promote metastatic potential and stemness in breast cancerMishra, A.; Parish, C.; Wong, M.; Licinio, J.; Blackburn, A.; Ahmad, A.
2019A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancerWarren, A.; Massie, C.; Watt, K.; Luko, K.; Orafidiya, F.; Selth, L.; Mohammed, H.; Chohan, B.; Menon, S.; Baridi, A.; Zhao, W.; Escriu, C.; Pungsrinont, T.; D Santos, C.; Yang, X.; Taylor, C.; Qureshi, A.; Zecchini, V.; Shaw, G.; Dehm, S.; et al.
2018Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesisWelsh, S.; Churchman, M.; Togni, M.; Mullighan, C.; Hagman, J.
2017The combination of metformin and valproic acid induces synergistic apoptosis in the presence of p53 and androgen signaling in prostate cancerTran, L.N.; Kichenadasse, G.; Butler, L.M.; Centenera, M.M.; Morel, K.L.; Ormsby, R.J.; Michael, M.Z.; Lower, K.M.; Sykes, P.J.
2011Regulation of progesterone receptor activity by cyclin dependent kinases 1 and 2 occurs in part by phosphorylation of the SRC-1 carboxyl-terminusMoore, N.; Weigel, N.
2016Computational reconstruction of NFκB pathway interaction mechanisms during prostate cancerBörnigen, D.; Tyekucheva, S.; Wang, X.; Rider, J.R.; Lee, G.S.; Mucci, L.A.; Sweeney, C.; Huttenhower, C.; Przytycka, T.M.
2013The genomic landscape of hypodiploid acute lymphoblastic leukemiaTo, L.
2018Tight junction protein claudin-2 promotes self-renewal of human colorectal cancer stem-like cellsPaquet-Fifield, S.; Koh, S.L.; Cheng, L.; Beyit, L.M.; Shembrey, C.; Mølck, C.; Behrenbruch, C.; Papin, M.; Gironella, M.; Guelfi, S.; Nasr, R.; Grillet, F.; Prudhomme, M.; Bourgaux, J.F.; Castells, A.; Pascussi, J.M.; Heriot, A.G.; Puisieux, A.; Davis, M.J.; Pannequin, J.; et al.
2013Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progressionButler, M.; Ricciardelli, C.; Tilley, W.; Hickey, T.
2014Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profilingPishas, K.; Neuhaus, S.; Clayer, M.; Schreiber, A.; Lawrence, D.; Perugini, M.; Whitfield, R.; Farshid, G.; Manavis, J.; Chryssidis, S.; Mayo, B.; Haycox, R.; Ho, K.; Brown, M.; D'Andrea, R.; Evdokiou, A.; Thomas, D.; Desai, J.; Callen, D.; Neilsen, P.

Discover